|
||||||
|
|
|
|
|
||
iSBTc ArchivesArchives | Presidential Award | Young Investigator Travel Award  Published Documents | Richard V. Smalley, MD Memorial Award News ReleaseFor Immediate Release For more information, contact: ISBTC DINNER SYMPOSIUM ADDRESSES IMMUNE RESPONSES AND STEM CELL TRANSPLANTATION Milwaukee--The International Society for Biological Therapy of Cancer (iSBTc) Dinner Symposium on "Harnessing Immune Responses and Stem Cell Transplantation as a Paradigm of Combination Therapy in Cancer" initiated a dialogue on the most recent advances utilizing immunotherapies in combination with hematopoietic stem cell transplantation (HSCT) in the treatment of cancer. Another aim of the Dinner Symposium was to facilitate collaborations on the development of clinical trials and experimental ideas between pharmaceutical and academic investigators with the goal of attaining better patient outcomes. The Dinner Symposium was a scientific educational program organized by Drs. William J. Murphy of the University of Nevada School of Medicine and Robert J. Soiffer of the Dana-Farber Cancer Institute. The Dinner Symposium addressed potential synergies in efficacy as well as potential toxicities using immunotherapy or molecular targeting in the context of HSCT in cancer. "Allogeneic transplantation is perhaps the first successful and most striking demonstration of cellular immune therapy in cancer patients," says Dr. Soiffer. "Yet the complex interplay between graft-versus-leukemia and graft-versus-host disease has not been fully elucidated, nor is there an effective way to safely maximize immune mediated anti-tumor activity. The introduction of new immunomodulatory agents under investigation by iSBTc delegates provides an unprecedented opportunity for collaborative interactions to help capitalize on the full potential of cellular immune therapy for our patients." Over 200 delegates from around the world representing basic scientists and clinical investigators from academia, industry, and regulatory agencies attended the Dinner Symposium. The Dinner Symposium provided a forum for clinicians, researchers, students, post-doctoral fellows, and allied health professionals to interact with senior investigators and leaders in the field to facilitate future research methods utilizing HSCT treatments. Founded in 1984, the International Society for Biological Therapy of Cancer (iSBTc) is an organization of clinicians, researchers, students, post-doctoral fellows, and allied health professionals dedicated to improving cancer patient outcomes by advancing the development and application of biological therapy through interaction, innovation and leadership. ### |
|
|
